¿Á½ÃÄÚµ·¾à ½ÃÀå : Á¦Ç° À¯Çü, Á¦Çü, ÀûÀÀÁõ, À¯Åë ä³Îº° - ¼¼°è ¿¹Ãø(2024-2032³â)
Oxycodone Drugs Market - By Product Type (Short-acting, Long-acting Oxycodone), Dosage Form (Tablets, Capsules), Indication (Neuropathic Pain, Cancer Pain), Distribution Channel (Hospital Pharmacies, Online Pharmacies) - Global Forecast 2024 - 2032
»óǰÄÚµå : 1518500
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 162 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,753,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,081,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿Á½ÃÄÚµ·¾à ½ÃÀå ±Ô¸ð´Â 2024-2032³â CAGR 5.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ³ëÀΠȯÀÚÀÇ ¸¸¼º ÅëÁõÀ» ¿ÏÈ­Çϱâ À§ÇØ ÀÌ·¯ÇÑ ¾à¹°À» ½ÅÁßÇÏ°Ô Ã³¹æÇϰí ÀÖ½À´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2050³â±îÁö Àü ¼¼°è 60¼¼ ÀÌ»ó Àα¸°¡ 21¾ï ¸íÀ¸·Î µÎ ¹è·Î ´Ã¾î³¯ °ÍÀ¸·Î ¿¹»óµÊ¿¡ µû¶ó ÀÇÁ¸¼º ¹× ¿À³²¿ë À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¿ÀÇÇ¿ÀÀÌµå »ç¿ë ¸ð´ÏÅ͸µ ¹× °ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á°è´Â ºñ¿ÀÇÇ¿ÀÀÌµå ¾à¹° ¹× Ä¡·á¹ý°ú °°Àº ´ëü ÅëÁõ °ü¸® Àü·«¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸°³¹ß ³ë·ÂÀº ÅëÁõ °ü¸®ÀÇ Àå±âÀûÀÎ °á°ú¸¦ º¸´Ù È®½ÇÇÏ°Ô º¸ÀåÇϱâ À§ÇØ ³ë³âÃþ¿¡ ƯȭµÈ º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀÎ Ä¡·á¹ýÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù.

Á¦Çüº°·Î´Â ÁÖ»çÁ¦°¡ 2024-2032³â ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿Á½ÃÄÚµ· ÁÖ»çÁ¦´Â Áï°¢ÀûÀÎ ¿ÏÈ­°¡ ÇÊ¿äÇÑ È¯ÀÚÀÇ ½ÉÇÑ ÅëÁõ °ü¸®¿¡ »ç¿ëµË´Ï´Ù. ÀÇ·á Àü¹®°¡µéÀº ƯÈ÷ ±Þ¼º±â ÀÇ·á ÇöÀå¿¡¼­ È¿°úÀûÀÎ ÅëÁõ Á¶ÀýÀ» º¸ÀåÇϱâ À§ÇØ ÀÌ·¯ÇÑ Áֻ縦 Åõ¿©ÇÕ´Ï´Ù. ¸¸¼º ÅëÁõÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ºÎÀÛ¿ë°ú ÀÇÁ¸¼º À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¿Á½ÃÄÚµ· ÁÖ»ç ÇÁ·ÎÅäÄÝÀ» ÃÖÀûÈ­Çϰí ÀÖ½À´Ï´Ù.

À¯Åë ä³Îº°·Î´Â ¿Â¶óÀÎ ¾à±¹ ºÎ¹®ÀÇ ¿Á½ÃÄÚµ·¾à »ê¾÷Àº ÅëÁõ °ü¸®°¡ ÇÊ¿äÇÑ È¯ÀÚµéÀÌ ¿©·¯ ÀǾàǰ¿¡ ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ 2024-2032³â Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿Â¶óÀÎ Ç÷§ÆûÀº ƯÈ÷ °Åµ¿ÀÌ ºÒÆíÇÑ È¯ÀÚµéÀÌ Æí¸®ÇÏ°Ô ÀǾàǰÀ» ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾à±¹µéÀº ¶ÇÇÑ ºÎÁ¤ »ç¿ëÀ» ¹æÁöÇϰí ÀûÀýÇÑ Á¶Á¦¸¦ º¸ÀåÇϱâ À§ÇÑ º¸¾È Á¶Ä¡¸¦ °­È­Çϱâ À§ÇØ ¾ö°ÝÇÑ °ËÁõ ÇÁ·Î¼¼½º¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î º¸¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿Á½ÃÄÚµ·¾à ½ÃÀå ±Ô¸ð´Â 2024-2032³â °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ÀÇ·á ÀÎÇÁ¶ó ±¸Ãà Áõ°¡¿Í ÀÇ·áºñ »ó½Â¿¡ ÈûÀÔ¾î APAC Áö¿ª Á¤ºÎ¿Í ¹Î°£ ºÎ¹®ÀÌ ÀÇ·á ½Ã¼³ Çö´ëÈ­ ¹× ÅëÁõ °ü¸® Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á½Ã¼³ Çö´ëÈ­¿Í ÅëÁõ°ü¸® Ä¡·á Á¢±Ù¼º È®´ë¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ°¡ È¿°úÀûÀ̰í ÅëÁ¦µÈ ÅëÁõ ¿ÏÈ­¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï ¿Á½ÃÄÚµ·ÀÇ Ç°Áú°ú °¡¿ë¼ºÀ» ³ôÀ̱â À§ÇÑ ÅõÀÚ°¡ Áö¼ÓÀûÀ¸·Î ÀÌ·ç¾îÁö°í ÀÖ´Â °Íµµ ¿Á½ÃÄÚµ·ÀÇ º¸±ÞÀ» ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¾àÁ¦ À¯Çüº°, 2021-2032³â

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Çüº°, 2021-2032³â

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÀûÀÀÁõº°, 2021-2032³â

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : À¯Åë ä³Îº°, 2021-2032³â

Á¦9Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

Á¦10Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Oxycodone Drugs Market size is projected to record 5.7% CAGR from 2024 to 2032, driven by their growing role in pain management for the aging population. Healthcare providers are carefully prescribing these medications to alleviate chronic pain in elderly patients.

With the expansion of the aging population, there is growing emphasis on monitoring and managing opioid use to mitigate risks of dependency and misuse. According to WHO, by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. Medical professionals are focusing on alternative pain management strategies, such as non-opioid medications and therapies. The ongoing R&D efforts are also creating safer and more effective treatments tailored to the specific needs of older adults for ensuring better long-term outcomes for pain management.

The overall oxycodone drugs market is segregated into drug type, dosage form, indication, distribution channel, and region.

In terms of dosage form, the injections segment is expected to record significant CAGR from 2024 to 2032. Oxycodone injections are used for managing severe pain in patients who require immediate relief. Medical professionals are administering these injections to ensure effective pain control especially in acute care settings. As the incidence of chronic pain increases, healthcare providers are optimizing oxycodone injection protocols to minimize side effects and dependency risks.

By distribution channel, the oxycodone drugs industry from the online pharmacies segment is projected to rise from 2024 to 2032, driven by the easy access to multiple drugs for patients in need of pain management. Online platforms play a crucial role in ensuring that individuals particularly those with mobility issues and can obtain their medications conveniently. These pharmacies are also implementing strict verification processes for enhancing security measures to prevent misuse and ensure proper dispensing.

Regionally, the Asia Pacific oxycodone drugs market size is projected to exhibit robust growth between 2024 and 2032, fueled by increasing healthcare infrastructure development and escalating healthcare expenditure. Governments and private sectors in APAC are investing on modernizing healthcare facilities and expanding access to pain management treatments. The ongoing investments for enhancing the quality and availability of oxycodone for ensuring that patients receive effective and regulated pain relief across the region will also push the product uptake.

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Drug Type, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 10 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â